OCULAR THERAPEUTIX INC (OCUL) Stock Analyst Earnings Estimates
NASDAQ:OCUL - Nasdaq - US67576A1007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 51.49M 18.31% | 58.443M 13.50% | 63.723M 9.03% | 56.178M -11.84% | 67.89M 20.85% | 122.67M 80.69% | 281.75M 129.68% | 577.06M 104.81% | 865.58M 50.00% | 1.172B 35.40% | 1.454B 24.06% | |
| EBITDA YoY % growth | -76.54M -1.22% | -79.399M -3.74% | -167.995M -111.58% | -257.897M -53.51% | 1.672B 748.32% | -195.075M -111.67% | -48.827M 74.97% | 157.34M 422.24% | 238.03M 51.28% | 322.11M 35.32% | 397.37M 23.36% | |
| EBIT YoY % growth | -78.65M -0.78% | -82.382M -4.75% | -171.781M -108.52% | -252.048M -46.73% | -261.548M -3.77% | -217.258M 16.93% | -128.821M 40.71% | 89.072M 169.14% | 322.77M 262.37% | 559.72M 73.41% | 779.34M 39.24% | |
| Operating Margin | -152.75% | -140.96% | -269.57% | -448.66% | -385.25% | -177.11% | -45.72% | 15.44% | 37.29% | 47.76% | 53.60% | |
| EPS YoY % growth | -0.96 -966.67% | -1.17 -21.87% | -1.47 -25.64% | -1.46 0.45% | -1.41 3.36% | -1.09 23.15% | -0.33 69.97% | 0.75 329.69% | 1.39 85.71% | 2.24 61.17% | 2.82 25.68% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 -77.57% | -0.39 -33.37% | -0.35 7.32% | -0.29 24.68% | -0.30 23.76% | -0.31 19.17% |
| Revenue Q2Q % growth | 14.664M -4.93% | 16.435M -3.79% | 15.191M 42.00% | 17.442M 29.59% | 17.748M 21.03% | 17.85M 8.61% |
| EBITDA Q2Q % growth | -69.651M -61.37% | -74.358M -58.92% | -62.281M 1.04% | -49.98M 23.85% | -51M 26.78% | -52.02M 30.04% |
| EBIT Q2Q % growth | -67.799M -47.40% | -67.764M -33.98% | -65.601M -2.64% | -55.896M 17.36% | -56.508M 16.65% | -57.426M 15.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.39 -50.00% | -0.36 | -0.03 | -7.83% |
| Q1 2025 Q2Q % growth | -0.38 45.71% | -0.30 | -0.08 | -26.63% |
| Q4 2024 Q2Q % growth | -0.29 17.14% | -0.26 | -0.03 | -12.97% |
| Q3 2024 Q2Q % growth | -0.22 -29.41% | -0.25 | 0.03 | 10.95% |
| Q2 2024 Q2Q % growth | -0.26 | -0.23 | -0.03 | -15.12% |
| Q1 2024 Q2Q % growth | -0.70 -79.49% | -0.20 | -0.50 | -258.50% |
| Q4 2023 Q2Q % growth | -0.35 -45.83% | -0.31 | -0.04 | -12.87% |
| Q3 2023 Q2Q % growth | -0.17 45.16% | -0.29 | 0.12 | 41.99% |
| Q2 2023 Q2Q % growth | -0.26 -4.00% | -0.31 | 0.05 | 15.60% |
| Q1 2023 Q2Q % growth | -0.39 -143.75% | -0.27 | -0.12 | -45.11% |
| Q4 2022 Q2Q % growth | -0.24 -380.00% | -0.26 | 0.02 | 7.12% |
| Q3 2022 Q2Q % growth | -0.31 -1,133.33% | -0.24 | -0.07 | -27.70% |
| Q2 2022 Q2Q % growth | -0.25 -127.27% | -0.23 | -0.02 | -6.56% |
| Q1 2022 Q2Q % growth | -0.16 -500.00% | -0.27 | 0.11 | 39.67% |
| Q4 2021 Q2Q % growth | -0.05 95.87% | -0.24 | 0.19 | 79.14% |
| Q3 2021 Q2Q % growth | 0.03 114.29% | -0.27 | 0.30 | 111.10% |
| Q2 2021 Q2Q % growth | -0.11 82.81% | -0.22 | 0.11 | 49.84% |
| Q1 2021 Q2Q % growth | 0.04 109.76% | -0.21 | 0.25 | 118.98% |
| Q4 2020 Q2Q % growth | -1.21 -128.30% | -0.17 | -1.04 | -611.75% |
| Q3 2020 Q2Q % growth | -0.21 47.50% | -0.25 | 0.04 | 15.10% |
| Q2 2020 Q2Q % growth | -0.64 -12.28% | -0.32 | -0.32 | -102.40% |
| Q1 2020 Q2Q % growth | -0.41 14.58% | -0.38 | -0.03 | -8.64% |
| Q4 2019 Q2Q % growth | -0.53 | -0.46 | -0.07 | -15.47% |
| Q3 2019 Q2Q % growth | -0.40 | -0.48 | 0.08 | 17.44% |
| Q2 2019 Q2Q % growth | -0.57 | -0.49 | -0.08 | -17.03% |
| Q1 2019 Q2Q % growth | -0.48 | -0.43 | -0.05 | -12.58% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 13.459M -18.14% | 13.518M | -59K | -0.44% |
| Q1 2025 Q2Q % growth | 10.698M -27.59% | 17.169M | -6.471M | -37.69% |
| Q4 2024 Q2Q % growth | 17.083M 15.41% | 17.549M | -466K | -2.66% |
| Q3 2024 Q2Q % growth | 15.425M 2.28% | 17.484M | -2.059M | -11.78% |
| Q2 2024 Q2Q % growth | 16.441M 8.26% | 16.14M | 301K | 1.86% |
| Q1 2024 Q2Q % growth | 14.774M 10.47% | 15.722M | -948K | -6.03% |
| Q4 2023 Q2Q % growth | 14.802M 5.13% | 16.021M | -1.219M | -7.61% |
| Q3 2023 Q2Q % growth | 15.081M 25.99% | 15.558M | -477K | -3.07% |
| Q2 2023 Q2Q % growth | 15.186M 23.77% | 14.943M | 243K | 1.63% |
| Q1 2023 Q2Q % growth | 13.374M 1.39% | 14.378M | -1.004M | -6.98% |
| Q4 2022 Q2Q % growth | 14.08M 14.38% | 13.804M | 276K | 2.00% |
| Q3 2022 Q2Q % growth | 11.97M -1.48% | 14.556M | -2.586M | -17.77% |
| Q2 2022 Q2Q % growth | 12.27M 4.69% | 14.532M | -2.262M | -15.57% |
| Q1 2022 Q2Q % growth | 13.19M 79.70% | 14.48M | -1.29M | -8.91% |
| Q4 2021 Q2Q % growth | 12.31M 67.48% | 14.727M | -2.417M | -16.41% |
| Q3 2021 Q2Q % growth | 12.15M 106.63% | 12.703M | -553K | -4.35% |
| Q2 2021 Q2Q % growth | 11.72M 646.50% | 11.042M | 678K | 6.14% |
| Q1 2021 Q2Q % growth | 7.34M 181.23% | 7.789M | -449K | -5.76% |
| Q4 2020 Q2Q % growth | 7.35M 225.22% | 9.954M | -2.604M | -26.16% |
| Q3 2020 Q2Q % growth | 5.88M 608.43% | 5.601M | 279K | 4.98% |
| Q2 2020 Q2Q % growth | 1.57M 141.54% | 1.529M | 41K | 2.68% |
| Q1 2020 Q2Q % growth | 2.61M 432.65% | 2.897M | -287K | -9.91% |
| Q4 2019 Q2Q % growth | 2.26M | 2.596M | -336K | -12.94% |
| Q3 2019 Q2Q % growth | 830K | 591.6K | 238.4K | 40.30% |
| Q2 2019 Q2Q % growth | 650K | 752.352K | -102.352K | -13.60% |
| Q1 2019 Q2Q % growth | 490K | 436.56K | 53.44K | 12.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.86% | -40.71% | 0% | -0.59% |
| Revenue | -1.27% | -17.04% | 0% | -0.41% |